BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25941097)

  • 21. [Surgical treatment of adrenal gland tumors].
    Klimenkov AA; Sel'chuk VIu; Nered SN; Itin AB; Gubina GI; Baronin AA; Kulaevskaia VP; Zakharova NE; Geĭdarov AKh; Gorbunov OV
    Vopr Onkol; 1998; 44(5):541-5. PubMed ID: 9884711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
    Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
    Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rare benign adrenal lesions.
    Dogra P; Sundin A; Juhlin CC; Calissendorff J; Falhammar H; Bancos I
    Eur J Endocrinol; 2023 Apr; 188(4):407-420. PubMed ID: 36943310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases.
    Duregon E; Volante M; Bollito E; Goia M; Buttigliero C; Zaggia B; Berruti A; Scagliotti GV; Papotti M
    Hum Pathol; 2015 Dec; 46(12):1799-807. PubMed ID: 26472162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperplasia and neoplasia of the adrenal gland.
    Kay S
    Pathol Annu; 1976; 11():103-39. PubMed ID: 1004940
    [No Abstract]   [Full Text] [Related]  

  • 26. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
    Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
    Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic guidelines for adrenal gland nodules: typing, assessment of biological potential and prognosis, molecular pathogenesis].
    Schröder S; Padberg B; Reincke M; Komminoth P
    Verh Dtsch Ges Pathol; 1997; 81():97-102. PubMed ID: 9474859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corticomedullary tumors of the adrenal glands. Report of two cases. Association of corticomedullary tumor with spindle cell sarcoma.
    Michal M; Havlicek F
    Pathol Res Pract; 1996 Nov; 192(11):1082-9. PubMed ID: 9122025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation in the neoplasms of the adrenal gland: Is there a prognostic role? An immunohistochemical study.
    Guadagno E; Russo D; Pignatiello S; Del Basso De Caro M
    Pathol Res Pract; 2020 Sep; 216(9):153070. PubMed ID: 32825943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCL-2 expression and inhibin-A in adrenal neoplasms: a comparative study.
    Fogt F; Zimmerman RL; Mulligan N; Vortmeyer AO; Poremba C; Harris CA; Alsaigh N; Tomaszewski JE; Nikulasson ST
    Int J Mol Med; 1999 Mar; 3(3):271-4. PubMed ID: 10028050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-cadherin expression in adrenal tumors: upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinoma.
    Khorram-Manesh A; Ahlman H; Jansson S; Nilsson O
    Endocr Pathol; 2002; 13(2):99-110. PubMed ID: 12165657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. USP10 Expression in Normal Adrenal Gland and Various Adrenal Tumors.
    Zeng Z; Zhou Z; Zhan N; Yuan J; Ye B; Gu L; Wang J; Jian Z; Xiong X
    Endocr Pathol; 2015 Dec; 26(4):302-8. PubMed ID: 26555087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinicopathologic features of myxoid adrenocortical adenomas].
    Wu HM; Liu C; Liu XH; Yao J; Liao JQ; Chen Y; Mei P; Huang LY; Liu YH
    Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):527-530. PubMed ID: 29996318
    [No Abstract]   [Full Text] [Related]  

  • 34. [Adrenocortical tumours].
    Saeger W
    Pathologe; 2003 Jul; 24(4):272-9. PubMed ID: 14513274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumours of the adrenal gland.
    Cardesa A; Handler AH; Kelman AD
    IARC Sci Publ; 1982; (34):281-6. PubMed ID: 7169259
    [No Abstract]   [Full Text] [Related]  

  • 36. CD44 expression in normal adrenal tissue and adrenal tumours.
    Barshack I; Goldberg I; Nass D; Olchovsky D; Kopolovic J
    J Clin Pathol; 1998 Jan; 51(1):52-4. PubMed ID: 9577373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.
    Mete O; Erickson LA; Juhlin CC; de Krijger RR; Sasano H; Volante M; Papotti MG
    Endocr Pathol; 2022 Mar; 33(1):155-196. PubMed ID: 35288842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenal cortical adenoma with adrenalin-type neurosecretory granules clinically mimicking a pheochromocytoma.
    Ivsic T; Komorowski RA; Sudakoff GS; Wilson SD; Datta MW
    Arch Pathol Lab Med; 2002 Dec; 126(12):1530-3. PubMed ID: 12456217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unique association of pheochromocytoma with contralateral nonfunctioning adrenal cortical adenoma.
    Morimoto S; Sasaki S; Moriguchi J; Miki S; Kawa T; Nakamura K; Fujita H; Itoh H; Nakata T; Takeda K; Nakagawa M
    Am J Hypertens; 1998 Jan; 11(1 Pt 1):117-21. PubMed ID: 9504459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
    Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.